Rheumatology International

Papers
(The TQCC of Rheumatology International is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Rheumatology university faculty opinion on coronavirus disease-19 (COVID-19) vaccines: the vaXurvey study from Egypt107
A hypothetical future in rheumatology: will we miss steroids in a steroid free-world?79
Cardiopulmonary exercise testing and prognosis in patients with systemic sclerosis without baseline pulmonary hypertension: a prospective cohort study78
COVID-19 pneumonia in a patient with granulomatosis with polyangiitis on rituximab: case-based review72
Cardiac involvement in primary Sjӧgren’s syndrome65
Demyelinating disease (multiple sclerosis) in a patient with psoriatic arthritis treated with adalimumab: a case-based review54
COVID-19 from a rheumatology perspective: bibliometric and altmetric analysis52
Protracted severe COVID-19 pneumonia following rituximab treatment: caution needed51
Epidemiology and genetics of granulomatosis with polyangiitis50
Risk factors of avascular necrosis in Takayasu arteritis: a cross sectional study49
Clinical performance of rheumatoid arthritis impact of disease score: a real-life evidence from the multicenter nationwide registry BioStaR43
Participation in physical activity decreased more in people with rheumatoid arthritis than the general population during the COVID-19 lockdown: a cross-sectional study39
Correction to: In vitro effects of curcumin on proinflammatory cytokines and expression of their genes in minor salivary gland tissue of patients with Sjogren’s syndrome39
Clonal expansion of large granular lymphocytes in patients with spondyloarthritis and psoriatic arthritis treated with TNFα inhibitors36
Large joints are progressively involved in rheumatoid arthritis irrespective of rheumatoid factor status—results from the early rheumatoid arthritis study35
Impact of the COVID-19 pandemic on the frequency of the pediatric rheumatic diseases34
The effects of golimumab on patient centric outcomes amongst rheumatoid arthritis patients in Greece. The GO-Q study33
Antibody response to inactivated COVID-19 vaccine (CoronaVac) in immune-mediated diseases: a controlled study among hospital workers and elderly30
Assessment of sarcopenia in patients with fibromyalgia25
Postdischarge rheumatic and musculoskeletal symptoms following hospitalization for COVID-19: prospective follow-up by phone interviews25
Alternatives for erroneous finger probe pulse oximetry in systemic sclerosis patients during COVID-19 pandemic24
ANCA-associated vasculitis following ChAdOx1 nCoV19 vaccination: case-based review23
Changing trends in rheumatoid arthritis mortality in Mexico, from 1998 to 201723
Rheumatoid factor and falsely elevated results in commercial immunoassays: data from an early arthritis cohort22
Tofacitinib in the treatment of skin and musculoskeletal involvement in patients with systemic sclerosis, evaluated by ultrasound21
Expanding the spectrum of reactive arthritis (ReA): classic ReA and infection-related arthritis including poststreptococcal ReA, Poncet’s disease, and iBCG-induced ReA20
Interferon-gamma release assays outcomes in healthy subjects following BNT162b2 mRNA COVID-19 vaccination20
Safety of the ChAdOx1 nCoV-19 and the BBV152 vaccines in 724 patients with rheumatic diseases: a post-vaccination cross-sectional survey20
Rituximab for refractory eosinophilic fasciitis: a case series with long-term follow-up and literature review20
Local and systemic reactogenicity of COVID-19 vaccine BNT162b2 in patients with systemic lupus erythematosus and rheumatoid arthritis20
Rehabilitative management of post-acute COVID-19: clinical pictures and outcomes19
Association of extended myositis panel results, clinical features, and diagnoses: a single-center retrospective observational study19
Resilience in women with primary Sjögren’s syndrome19
Uric acid extrarenal excretion: the gut microbiome as an evident yet understated factor in gout development18
Cardiovascular disease detection using machine learning and carotid/femoral arterial imaging frameworks in rheumatoid arthritis patients18
Mental health and quality of life for people with rheumatoid arthritis or ankylosing spondylitis in Aotearoa New Zealand following the COVID-19 national lockdown18
Post-COVID-19 exacerbation of fibrodysplasia ossificans progressiva with multiple flare-ups and extensive heterotopic ossification in a 45-year-old female patient17
Evaluation of Big Five personality factors in women with fibromyalgia: a cross-sectional study17
Managing ANCA-associated vasculitis during the COVID-19 pandemic: results from an online survey16
The synergistic role of TNFA − 308G/A and IL10 − 1082A/G polymorphisms in ankylosing spondylitis16
The impact of COVID-19 on familial Mediterranean fever: a nationwide study16
0.17927598953247